Doha – May 13, 2024: Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have published a study that marks the introduction to Qatar of some of the world’s most advanced analytical tools for discovering the links between genetic variations, proteins and a wide range of diseases.

Using a new tool to measure proteins, WCM-Q researchers Dr. Karsten Suhre and Dr. Frank Schmidt analyzed the blood samples of more than 320 individuals from a multi-ethnic cohort in Qatar. The tool, called the Proteograph Product Suite, allowed the WCM-Q researchers to quantify more than 18,000 different peptides (molecular structures formed of amino acids) fro


Leave a Reply